Amalgamated Bank decreased its holdings in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 39.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,598 shares of the health services provider's stock after selling 7,533 shares during the period. Amalgamated Bank's holdings in Universal Health Services were worth $2,656,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Point72 Asset Management L.P. grew its position in shares of Universal Health Services by 362.3% during the second quarter. Point72 Asset Management L.P. now owns 322,626 shares of the health services provider's stock worth $59,663,000 after acquiring an additional 252,846 shares during the last quarter. Marshall Wace LLP grew its position in shares of Universal Health Services by 357.9% during the second quarter. Marshall Wace LLP now owns 261,221 shares of the health services provider's stock worth $48,308,000 after acquiring an additional 204,178 shares during the last quarter. Lazard Asset Management LLC grew its position in shares of Universal Health Services by 1,191.8% during the first quarter. Lazard Asset Management LLC now owns 215,215 shares of the health services provider's stock worth $39,267,000 after acquiring an additional 198,555 shares during the last quarter. Lord Abbett & CO. LLC bought a new position in shares of Universal Health Services during the first quarter worth about $25,032,000. Finally, Goldentree Asset Management LP bought a new position in shares of Universal Health Services during the first quarter worth about $21,378,000. Institutional investors own 86.05% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have recently commented on the stock. Wells Fargo & Company upped their price target on shares of Universal Health Services from $275.00 to $285.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. Stephens reiterated an "equal weight" rating and issued a $200.00 target price on shares of Universal Health Services in a research report on Thursday, July 25th. Barclays increased their target price on shares of Universal Health Services from $256.00 to $271.00 and gave the company an "overweight" rating in a research report on Friday, October 25th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $219.00 target price on shares of Universal Health Services in a research report on Friday, October 25th. Finally, The Goldman Sachs Group increased their target price on shares of Universal Health Services from $200.00 to $229.00 and gave the company a "buy" rating in a research report on Tuesday, July 30th. Six research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Universal Health Services currently has an average rating of "Moderate Buy" and a consensus target price of $231.14.
Read Our Latest Stock Analysis on Universal Health Services
Universal Health Services Trading Up 0.5 %
UHS stock traded up $1.06 during mid-day trading on Monday, reaching $208.56. 478,951 shares of the stock traded hands, compared to its average volume of 680,827. The company has a current ratio of 1.39, a quick ratio of 1.28 and a debt-to-equity ratio of 0.69. Universal Health Services, Inc. has a 52-week low of $129.34 and a 52-week high of $243.25. The company has a market cap of $13.91 billion, a P/E ratio of 13.80, a P/E/G ratio of 0.66 and a beta of 1.29. The stock's fifty day moving average is $224.42 and its 200-day moving average is $204.35.
Universal Health Services (NYSE:UHS - Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The health services provider reported $3.71 EPS for the quarter, missing analysts' consensus estimates of $3.75 by ($0.04). Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. The firm had revenue of $3.96 billion for the quarter, compared to analysts' expectations of $3.90 billion. During the same period in the prior year, the company posted $2.55 earnings per share. Universal Health Services's quarterly revenue was up 11.3% compared to the same quarter last year. As a group, sell-side analysts expect that Universal Health Services, Inc. will post 15.93 earnings per share for the current year.
Universal Health Services declared that its board has approved a share repurchase program on Wednesday, July 24th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the health services provider to buy up to 8% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its stock is undervalued.
About Universal Health Services
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
See Also
Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.